Status:
UNKNOWN
Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study
Lead Sponsor:
University Hospital Southampton NHS Foundation Trust
Collaborating Sponsors:
Solent NHS Trust
Conditions:
S. Pneumoniae
Pneumococcal Conjugate Vaccine
Eligibility:
All Genders
Up to 4 years
Brief Summary
The investigators intend to investigate the carriage of pneumococci and other respiratory microbes since the introduction of pneumococcal conjugate vaccines (Prevenar 7 and Prevenar 13). The principal...
Detailed Description
Streptococcus pneumoniae (the pneumococcus) is an important cause of pneumonia, meningitis and bacteraemia worldwide. The prevention of invasive pneumococcal disease (IPD) by immunisation has been a k...
Eligibility Criteria
Inclusion
- All children aged 4 years or under, attending the recruitment sites during the recruitment period will be invited to participate through their parents or legal guardian.
Exclusion
- One child per family
- Children with obstructed nasal passages
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT04401488
Start Date
October 1 2014
End Date
March 31 2022
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Southampton Foundation NHS Trust
Southampton, Hampshire, United Kingdom, SO16 6YD